"Cannabidiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compound isolated from Cannabis sativa extract.
Below are MeSH descriptors whose meaning is more general than "Cannabidiol".
Below are MeSH descriptors whose meaning is more specific than "Cannabidiol".
This graph shows the total number of publications written about "Cannabidiol" by people in Harvard Catalyst Profiles by year, and whether "Cannabidiol" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2015 | 2 | 2 | 4 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 4 | 0 | 4 |
| 2019 | 5 | 0 | 5 |
| 2020 | 10 | 0 | 10 |
| 2021 | 13 | 1 | 14 |
| 2022 | 4 | 0 | 4 |
| 2023 | 2 | 0 | 2 |
Below are the most recent publications written about "Cannabidiol" by people in Profiles.
-
"Bones and Joints" The Role of Cannabidiol (CBD) in Musculoskeletal Health. Bull Hosp Jt Dis (2013). 2023 Mar; 81(1):59-63.
-
Long-term efficacy and safety of cannabidiol in patients with treatment-resistant epilepsies: Four-year results from the expanded access program. Epilepsia. 2023 03; 64(3):619-629.
-
Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain. BMJ Open. 2022 09 19; 12(9):e063613.
-
Post-legalization Consumption of Cannabis at Massachusetts General Hospital Dental Group. J Contemp Dent Pract. 2022 Sep 23; 23(6):618-622.
-
Cannabidiol activates neuronal Kv7 channels. Elife. 2022 02 18; 11.
-
Electroencephalographic changes in purified pharmaceutical cannabidiol therapy. Epilepsy Behav. 2022 03; 128:108558.
-
Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial. Epilepsia. 2022 02; 63(2):426-439.
-
A scoping review of the use of cannabidiol in psychiatric disorders. Psychiatry Res. 2022 02; 308:114347.
-
A cannabidiol-containing alginate based hydrogel as novel multifunctional wound dressing for promoting wound healing. Biomater Adv. 2022 Mar; 134:112560.
-
Letter to the Editor: A Positive Tetrahydrocannabinol on Urine Screen After Cannabidiol Oil Use in an Adolescent. J Child Adolesc Psychopharmacol. 2022 05; 32(4):242-243.